ArticleThe Journal of allergy and clinical immunology2024

Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia.

Paneez Khoury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.